Epilepsy drug target implications for sleep disruption in brain disorders

A study using the mutant fruitfly sleepless confirmed that the enzyme GABA transaminase, a target of some epilepsy drugs, contributes to sleep loss. The findings shed light on mechanisms that may be shared between sleep disruption and some neurological disorders. A better understanding of this connection could enable treatments that target both types of symptoms and perhaps provide better therapeutic efficacy.